This gradual escalation allows patients to develop tolerance to gastrointestinal effects while achieving progressively greater appetite suppression and weight loss
Ideal candidates typically: Have struggled with weight control despite lifestyle modification Display signs of insulin resistance or metabolic syndrome Require medical assistance to prevent progression of obesity-related diseases Exclusion criteria may include individuals with a history of certain endocrine disorders, pancreatitis, or specific gastrointestinal diseases
The more complex the test, the more it will cost
The WHO guideline specifically recommends GLP-1 therapies for adults with obesity, defined as BMI 30 or higher
American Journal of Physiology-Endocrinology and Metabolism , 302(4), E541E549
Its a good idea to perform a patch test before regular use, especially for individuals with highly sensitive skin